99% Savings - Buy Just @1 Rs X
Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine is used -
Severe
Moderate
Mild
Is the use of Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine safe for pregnant women?
Pregnant women can consume [medicine]. Though Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine has mild side effects when taken during pregnany
Is the use of Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine safe during breastfeeding?
Breastfeeding women can take Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine as it bears very minor side effects for them.
What is the effect of Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine on the Kidneys?
Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine rarely harms the kidneys.
What is the effect of Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine on the Liver?
Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine has very mild side effects on the liver.
What is the effect of Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine on the Heart?
Very few cases of side effects of Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine on the heart have been reported.
Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine unless your doctor advises you to do so -
Is this Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine habit forming or addictive?
Forming a habit of Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine has not been reported.
Interaction between Food and Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine
When consumed with certain foods, Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine.
Yes, Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed such as fluid retention (swelling in your hands or ankles), increased appetite, increased sweating, and stomach upset. Do not hesitate to inform your doctor if you are facing any of the above.
Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine works by suppressing body's normal immune response to inflammation which is responsible for symptoms such as swelling, redness and itching. This results in decreased inflammation and provides relief from the symptoms associated with it.
Yes, Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine is used in the treatment of gastritis. It helps by preventing the excess acid secretion in the stomach and additionally relieving the symptoms of gastritis such as stomach pain, stomach inflammation, and acid reflux.
Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine is a brand name of beclomethasone. It is a prescription drug that belongs to the class of medicine called steroids (corticosteroid). It comes in form of an inhaler, tablet, solution, injection, and topical cream. It has potent anti-inflammatory properties. It is used in the treatment of inflammatory joint diseases, multiple sclerosis, inflammation, allergic conditions, and adrenal insufficiency. It is also used to diagnose Cushing's syndrome.
Yes, Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine can raise blood sugar in diabetic patients. It raises the blood sugar level by increasing the glucose production in the body and decreasing the effect of insulin which is produced by the pancreas. However, it is best to consult your doctor if you have diabetes while taking Beclometasone + Chloramphenicol + Clotrimazole + Lidocaine.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Chloromycetin sodium succinate (chaloramphenicol sodium succinate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 739-742
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775